Tyrosine Kinase Inhibitors CD Protein Inhibitors Immunotherapy Proteasome Inhibitors BCL Inhibitors Immune Checkpoint Inhibitors Chemokine Interleukins Epigenetics Kinase Inhibitors | Waldenstrom Macroglobulinemia | Diffuse Large B Cell Lymphoma | Lymphoma | Marginal Zone Lymphoma | Multiple Myeloma | Non-Hodgkin’s Lymphoma |
---|---|---|---|---|---|---|
ibrutinib | ||||||
zanubrutinib | ||||||
daratumumab | ||||||
rituximab + ixazomib | ||||||
X4P-001 | ||||||
orelabrutinib | ||||||
ZPR | ||||||
venetoclax | ||||||
lenalidomide + bortezomib | ||||||
KT-413 | ||||||
rituximab |